- $82.46bn
- $137.91bn
- $372.81bn
- 71
- 84
- 97
- 98
Annual balance sheet for CVS Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 10,854 | 12,525 | 15,723 | 11,455 | 10,993 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 21,742 | 24,431 | 27,276 | 35,227 | 36,469 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 56,369 | 60,008 | 65,633 | 67,858 | 68,645 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 33,335 | 32,018 | 30,745 | 30,435 | 28,937 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 230,715 | 232,999 | 228,275 | 249,728 | 253,215 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 62,017 | 67,807 | 69,421 | 79,189 | 84,609 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 161,326 | 157,924 | 156,806 | 173,267 | 177,655 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 69,389 | 75,075 | 71,469 | 76,461 | 75,560 |
Total Liabilities & Shareholders' Equity | 230,715 | 232,999 | 228,275 | 249,728 | 253,215 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |